Calcitonin Screening in Nodular Thyroid Disease: Is There a Definitive Answer?

Journal: European thyroid journal
Published Date: Dec 5, 2018

Abstract

INTRODUCTION: Calcitonin (Ctn) is a hormone secreted by thyroid "C" cells and is considered an excellent marker for medullary thyroid carcinoma (MTC). However, the use of Ctn to screen patients with nodular thyroid disease (NTD) remains controversial.

Authors

  • Catarina Silvestre
    Department of Endocrinology, Diabetes and Metabolism, Santa Maria Hospital, Lisbon, Portugal.
  • Joaquim Sampaio Matias
    Department of Laboratorial Medicine, Santa Maria Hospital, Lisbon, Portugal.
  • Helena Proença
    Department of Laboratorial Medicine, Santa Maria Hospital, Lisbon, Portugal.
  • Maria João Bugalho
    Department of Endocrinology, Diabetes and Metabolism, Santa Maria Hospital, Lisbon, Portugal.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals